AKE’s merger with Livent is basically complete, which creates an operation with more scale, but it’s the lithium price that will continue to dictate its share price through 2024/5. We like the risk/reward towards AKE around current levels, but we would leave plenty of funds to average in case the established downtrend extends lower, as has so often been the case through 2023. We are watching out for a catalyst to address the lithium price decline before it is likely MM will be on the buy side in a major way.
- We believe AKE is now entering an accumulation area, but we would be treading carefully, it’s already fallen 50% from its 2023 high, so why not another 10-20%?
MM likes AKE into any ongoing weakness
Add To Hit List
